Daohong Zhou, M.D., a professor of pharmacodynamics, has received multiple recent grants, including a multiple principal investigator R01 from the National Cancer Institute, alongside his longtime collaborator Guangrong Zheng, Ph.D., an associate professor of medicinal chemistry Dr. Daohong Zhou The grant titled “Inhibition of Bcl-xL by Targeted Degradation” will carry…
The University of Florida College of Pharmacy awarded the three prestigious fellowships at a virtual award ceremony Oct. 13.
Guillaume de Lartigue, Ph.D., an assistant professor of pharmacodynamics, and Alan Moreira de Araujo, Ph.D., a postdoctoral associate, were invited to write an article in one of the leading journals in their field, Nature Reviews Gastroenterology & Hepatology. The article titled, “Non-canonical cholinergic anti-inflammatory pathway in IBD,”…
Congratulations to Meera Rath for successfully defending her dissertation, “Exploring the role of microglia in chronic voluntary binge ethanol consumption mouse model,” on Oct. 21. Committee members included Bin Liu, Ph.D.; Joanna Peris, Ph.D.; Jay McLaughlin, Ph.D.; Stanley Stevens, Jr., Ph.D.; Eric Krause, Ph.D.; and Christopher Vulpe, M.D., Ph.D. Rath…
The grant will address the unmet need for new, safer analgesics by developing novel mitragynine analogs.
UF researchers found kratom delivered significant pain-relieving benefits, reduced opioid withdrawal symptoms and caused minimal respiratory depression.
Graduate students in the department of pharmacodynamics Ariana Brice-Tutt and Lisa Wilson won awards from the UF College of Pharmacy at the Graduate Students Social on Oct. 13. Brice-Tutt won the Robert and Stephanie Ruffolo Graduate Education and Research Fellowship and Wilson won the Avery Advancing Women in Pharmaceutical Sciences Endowment Award.
The award recognizes a teaching partnership that exemplifies teamwork in developing and delivering application exercises within a course or module.
This paper was highlighted by Cancer Discovery one of the top journals in cancer research.
When it became evident in late March that most research would be halted because of COVID-19, Dr. Jay McLaughlin’s lab went into high gear.